DBVT Q1 2022 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$5M

Operating Income

-$19M

Net Income

-$17M

EPS (Diluted)

$-1.50

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$118M

Total Liabilities

$36M

Stockholders' Equity

$82M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$3M	-100.0%
Gross Profit	-$5M	$3M	-263.7%
Operating Income	-$19M	-$30M	+35.0%
Net Income	-$17M	-$29M	+43.4%